Company: INKT
Filing Date: 2025-01-21
Form Type: 8-K
Source: 0001193125-25-009595
Chunk: 0

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-01-21
Form: 8-K
Item: Item 5.03
Chunk 0
---
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On January 17, 2025, MiNK Therapeutics, Inc. (the “ Company”) filed a Certificate of Amendment (the “ Certificate of Amendment”) to its Amended and Restated Certificate of Incorporation (the “ Certificate of Incorporation”) with the Secretary of State of the State of Delaware to effect a reverse stock split of the Company’s issued and outstanding common stock, par value $0.00001 (the “ Common Stock”) at a ratio of1-for-10(the “ Reverse Stock Split”). Pursuant to the Certificate of Amendment, the Reverse Stock Split will be effective at 12:01 a. m., Eastern Time, on January 28, 2025. The Company expects that upon the opening of trading on January 28, 2025, the Company’s Common Stock will begin trading on a post-split basis under CUSIP number 603693 201.

As discussed below, on January 17, 2025, the Company’s stockholders approved a proposal to amend the Certificate of Incorporation in accordance with the Certificate of Amendment at a Special Meeting of Stockholders of the Company (the “ Special Meeting”). The Certificate of Amendment is filed as Exhibit 3.1 to this Current Report on Form8-K.